Edition:
United States

Adaptimmune Therapeutics PLC (ADAP.OQ)

ADAP.OQ on NASDAQ Stock Exchange Global Select Market

3.66USD
17 Jun 2019
Change (% chg)

$0.06 (+1.67%)
Prev Close
$3.60
Open
$3.64
Day's High
$3.78
Day's Low
$3.51
Volume
90,601
Avg. Vol
80,085
52-wk High
$14.52
52-wk Low
$3.20

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

David Mott

52 2017 Non-Executive Chairman of the Board

James Noble

55 2014 Chief Executive Officer, Director

Adrian Rawcliffe

46 2015 Chief Financial Officer

William Bertrand

53 2017 Chief Operating Officer

Sebastien Desprez

2017 Vice President - Communications and Investor Relations